Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03841032 · ClinicalTrials.gov registry record · NA
4 Week In-Use Study Evaluating How Well-Tolerated a Skin Care Product Is on Adults With Facial Redness
A NA study of Rosacea, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT03841032: Completed NA study of Rosacea, sponsored by Bayer.
NCT03841032 is a NA study of Rosacea that has completed, run by Bayer. The registered enrollment target is 35 participants, below the 242-participant average among 23 other Rosacea trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03841032, a NA study of Rosacea, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate if the test sunscreen skin care product will be well-tolerated and help facial redness when applied to the face after 4 weeks.
Conditions Studied
Interventions
- DRUG Coppertone, BAY1183345
Study Locations (1)
Virginia
- The Education & Research Foundation, Inc. - Lynchburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2019-01-28 |
| Est. Completion | 2019-02-25 |
| Phase | NA |
What the finished NCT03841032 record still lists
NCT03841032 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 242-participant average among 23 other Rosacea trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Rosacea appearing as the primary indexed condition, and to 1 intervention - of which Coppertone, BAY1183345 is the first listed.
NCT03841032 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT03841032 about?
NCT03841032 is a clinical study titled "4 Week In-Use Study Evaluating How Well-Tolerated a Skin Care Product Is on Adults With Facial Redness". The purpose of this study is to evaluate if the test sunscreen skin care product will be well-tolerated and help facial redness when applied to the face after 4 weeks.
What is the current status of trial NCT03841032?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2019-01-28. Estimated completion is 2019-02-25.
What conditions does trial NCT03841032 study?
This clinical trial studies the following conditions: Rosacea.
What interventions are being tested in trial NCT03841032?
The interventions under investigation include: Coppertone, BAY1183345 (DRUG).
Who is sponsoring clinical trial NCT03841032?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03841032 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rosacea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03841032's enrollment target sits among peer trials
35 19th of 23 higher than 5 of 23 other Rosacea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rosacea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Oral Supplement Containing L-Histidine and Antioxidants on the Skin Barrier Function and Systemic Inflammation in Rosacea
RECRUITING · NA
-
The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
RECRUITING · NA
-
A Study to Evaluate the Safety, Tolerability, and Effects of Anatabloc® Crème in Rosacea
COMPLETED · NA
-
Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea
RECRUITING · Phase 2
-
Analysis of the Microbiome in Rosacea
ACTIVE NOT RECRUITING · Early Phase 1
-
Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI